Allergan Development Deal Ends
- Share via
Dow Jones
IRVINE — Allergan Inc. and Peptech Ltd. in England have terminated their agreement to develop a psoriasis treatment.
Irvine-based Allergan, an eye-care products company, said Peptech has determined that further work is required to assess the optimal treatment regimen for the product, GMDP.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
